Page last updated: 2024-11-04

gatifloxacin and Eye Infections, Parasitic

gatifloxacin has been researched along with Eye Infections, Parasitic in 2 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Eye Infections, Parasitic: Mild to severe infections of the eye and its adjacent structures (adnexa) by adult or larval protozoan or metazoan parasites.

Research Excerpts

ExcerptRelevanceReference
"Gatifloxacin showed lower resistance levels than moxifloxacin."1.38[In vitro antibiotic susceptibility to fluoroquinolones]. ( Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Thongseesuksai, T1
Wongwai, P1
Boonmars, T1
Sanpool, O1
Laummaunwai, P1
Wong, CA1
Galvis, V1
Tello, A1
Villareal, D1
Rey, JJ1

Other Studies

2 other studies available for gatifloxacin and Eye Infections, Parasitic

ArticleYear
Evaluating the in vitro efficacy of gatifloxacin, levofloxacin and gentamicin against Acanthamoeba cysts.
    International ophthalmology, 2020, Volume: 40, Issue:2

    Topics: Acanthamoeba; Amebiasis; Animals; Eye Infections, Parasitic; Gatifloxacin; Gentamicins; Humans; Levo

2020
[In vitro antibiotic susceptibility to fluoroquinolones].
    Archivos de la Sociedad Espanola de Oftalmologia, 2012, Volume: 87, Issue:3

    Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia;

2012